Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus

Zika virus (ZIKV) is a mosquito borne pathogen, belongs to Flaviviridae family having a positive-sense single-stranded RNA genome, currently known for causing large epidemics in Brazil. Its infection can cause microcephaly, a serious birth defect during pregnancy. The recent outbreak of ZIKV in Febr...

Full description

Saved in:
Bibliographic Details
Main Authors: Maheswata Sahoo, Lingaraja Jena, Sangeeta Daf, Satish Kumar
Format: Article
Language:English
Published: BioMed Central 2016-09-01
Series:Genomics & Informatics
Subjects:
Online Access:http://genominfo.org/upload/pdf/gni-14-104.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572894164549632
author Maheswata Sahoo
Lingaraja Jena
Sangeeta Daf
Satish Kumar
author_facet Maheswata Sahoo
Lingaraja Jena
Sangeeta Daf
Satish Kumar
author_sort Maheswata Sahoo
collection DOAJ
description Zika virus (ZIKV) is a mosquito borne pathogen, belongs to Flaviviridae family having a positive-sense single-stranded RNA genome, currently known for causing large epidemics in Brazil. Its infection can cause microcephaly, a serious birth defect during pregnancy. The recent outbreak of ZIKV in February 2016 in Brazil realized it as a major health risk, demands an enhanced surveillance and a need to develop novel drugs against ZIKV. Amodiaquine, prochlorperazine, quinacrine, and berberine are few promising drugs approved by Food and Drug Administration against dengue virus which also belong to Flaviviridae family. In this study, we performed molecular docking analysis of these drugs against nonstructural 3 (NS3) protein of ZIKV. The protease activity of NS3 is necessary for viral replication and its prohibition could be considered as a strategy for treatment of ZIKV infection. Amongst these four drugs, berberine has shown highest binding affinity of –5.8 kcal/mol and it is binding around the active site region of the receptor. Based on the properties of berberine, more similar compounds were retrieved from ZINC database and a structure-based virtual screening was carried out by AutoDock Vina in PyRx 0.8. Best 10 novel drug-like compounds were identified and amongst them ZINC53047591 (2-(benzylsulfanyl)-3-cyclohexyl-3H-spiro[benzo[h]quinazoline-5,1'-cyclopentan]-4(6H)-one) was found to interact with NS3 protein with binding energy of –7.1 kcal/mol and formed H-bonds with Ser135 and Asn152 amino acid residues. Observations made in this study may extend an assuring platform for developing anti-viral competitive inhibitors against ZIKV infection.
format Article
id doaj-art-a63224df3c7844edb050e323db1846b7
institution Kabale University
issn 1598-866X
2234-0742
language English
publishDate 2016-09-01
publisher BioMed Central
record_format Article
series Genomics & Informatics
spelling doaj-art-a63224df3c7844edb050e323db1846b72025-02-02T06:21:31ZengBioMed CentralGenomics & Informatics1598-866X2234-07422016-09-0114310411110.5808/GI.2016.14.3.104167Virtual Screening for Potential Inhibitors of NS3 Protein of Zika VirusMaheswata Sahoo0Lingaraja Jena1Sangeeta Daf2Satish Kumar3Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442-102, India.Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442-102, India.Obstetrics & Gynaecology, Datta Meghe Institute of Medical Sciences (Deemed University), Nagpur 440-022, India.Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442-102, India.Zika virus (ZIKV) is a mosquito borne pathogen, belongs to Flaviviridae family having a positive-sense single-stranded RNA genome, currently known for causing large epidemics in Brazil. Its infection can cause microcephaly, a serious birth defect during pregnancy. The recent outbreak of ZIKV in February 2016 in Brazil realized it as a major health risk, demands an enhanced surveillance and a need to develop novel drugs against ZIKV. Amodiaquine, prochlorperazine, quinacrine, and berberine are few promising drugs approved by Food and Drug Administration against dengue virus which also belong to Flaviviridae family. In this study, we performed molecular docking analysis of these drugs against nonstructural 3 (NS3) protein of ZIKV. The protease activity of NS3 is necessary for viral replication and its prohibition could be considered as a strategy for treatment of ZIKV infection. Amongst these four drugs, berberine has shown highest binding affinity of –5.8 kcal/mol and it is binding around the active site region of the receptor. Based on the properties of berberine, more similar compounds were retrieved from ZINC database and a structure-based virtual screening was carried out by AutoDock Vina in PyRx 0.8. Best 10 novel drug-like compounds were identified and amongst them ZINC53047591 (2-(benzylsulfanyl)-3-cyclohexyl-3H-spiro[benzo[h]quinazoline-5,1'-cyclopentan]-4(6H)-one) was found to interact with NS3 protein with binding energy of –7.1 kcal/mol and formed H-bonds with Ser135 and Asn152 amino acid residues. Observations made in this study may extend an assuring platform for developing anti-viral competitive inhibitors against ZIKV infection.http://genominfo.org/upload/pdf/gni-14-104.pdfdrug designflavivirushigh throughput screening methodsNS3 proteinzika virus
spellingShingle Maheswata Sahoo
Lingaraja Jena
Sangeeta Daf
Satish Kumar
Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
Genomics & Informatics
drug design
flavivirus
high throughput screening methods
NS3 protein
zika virus
title Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
title_full Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
title_fullStr Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
title_full_unstemmed Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
title_short Virtual Screening for Potential Inhibitors of NS3 Protein of Zika Virus
title_sort virtual screening for potential inhibitors of ns3 protein of zika virus
topic drug design
flavivirus
high throughput screening methods
NS3 protein
zika virus
url http://genominfo.org/upload/pdf/gni-14-104.pdf
work_keys_str_mv AT maheswatasahoo virtualscreeningforpotentialinhibitorsofns3proteinofzikavirus
AT lingarajajena virtualscreeningforpotentialinhibitorsofns3proteinofzikavirus
AT sangeetadaf virtualscreeningforpotentialinhibitorsofns3proteinofzikavirus
AT satishkumar virtualscreeningforpotentialinhibitorsofns3proteinofzikavirus